Variant report
Variant | nsv1023656 |
---|---|
Chromosome Location | chr8:6102848-6114273 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6106618..6108795-chr8:6113891..6116770,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253880 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138963493 | chr8:6104018-6104019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186466402 | chr8:6104025-6104026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189719439 | chr8:6104032-6104033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6995691 | chr8:6104057-6104058 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs542909519 | chr8:6104077-6104078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6982565 | chr8:6104080-6104081 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs571691968 | chr8:6104102-6104103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540794694 | chr8:6104119-6104120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6559122 | chr8:6104157-6104158 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs73520095 | chr8:6104170-6104171 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs543559143 | chr8:6104174-6104175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76494875 | chr8:6104178-6104179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529245739 | chr8:6104179-6104180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549283208 | chr8:6104198-6104199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs180951821 | chr8:6104200-6104201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528462208 | chr8:6104215-6104216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551602007 | chr8:6104221-6104222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144724915 | chr8:6104240-6104241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186286106 | chr8:6104246-6104247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557576744 | chr8:6104267-6104268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567508950 | chr8:6104269-6104270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191579626 | chr8:6104271-6104272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6559123 | chr8:6104273-6104274 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs571729436 | chr8:6104274-6104275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566648178 | chr8:6104293-6104294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376846470 | chr8:6104314-6104315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs386721726 | chr8:6104315-6104316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76361837 | chr8:6104317-6104318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10092383 | chr8:6104318-6104319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145225541 | chr8:6104319-6104320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559167311 | chr8:6104320-6104321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543144212 | chr8:6104332-6104333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377083536 | chr8:6104335-6104336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563509837 | chr8:6104338-6104339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148118077 | chr8:6104350-6104351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs6559124 | chr8:6104388-6104389 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs569278131 | chr8:6104412-6104413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141825897 | chr8:6104413-6104414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6559125 | chr8:6104415-6104416 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs551708197 | chr8:6104423-6104424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565129386 | chr8:6104452-6104453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531072554 | chr8:6104484-6104485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17465994 | chr8:6104491-6104492 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs147247743 | chr8:6104495-6104496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536419684 | chr8:6104519-6104520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117183827 | chr8:6104533-6104534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116299063 | chr8:6104535-6104536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538961583 | chr8:6104548-6104549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557776286 | chr8:6104552-6104553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541941766 | chr8:6104602-6104603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6104000-6105600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr8:6104000-6106000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr8:6104400-6107400 | Enhancers | Primary hematopoietic stem cells | blood |
4 | chr8:6104800-6105200 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr8:6105000-6107400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:6105200-6105600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr8:6105600-6106400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr8:6106000-6106400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr8:6106400-6111200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr8:6106400-6111200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr8:6107000-6107200 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr8:6107400-6110200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
13 | chr8:6107400-6110600 | Weak transcription | Primary hematopoietic stem cells | blood |
14 | chr8:6110200-6110600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr8:6110600-6111000 | Enhancers | Primary hematopoietic stem cells | blood |
16 | chr8:6110600-6111800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
17 | chr8:6111000-6112400 | Weak transcription | Primary hematopoietic stem cells | blood |
18 | chr8:6111200-6112200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr8:6111200-6112200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr8:6111800-6112800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
21 | chr8:6112200-6112600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr8:6112200-6112800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
23 | chr8:6112400-6112600 | Enhancers | Primary hematopoietic stem cells | blood |
24 | chr8:6112800-6114800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |